Effects of glucose, insulin, and insulin-like growth factor-I on glucose transport activity in cultured rat vascular smooth muscle cells

Atherosclerosis

Volumn 127, Issue 1, 1996, Pages 49-57

  Fujiwara, Ryuichi ^a,b   Nakai, Tsuguhiko ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b JOSLIN DIABETES CENTER   (United States)

Author keywords

glucose transport activity; insulin; insulin resistance; insulin like growth factor I; phosphatidylinositol 3 kinase; vascular smooth muscle cells

Indexed keywords

DEOXYGLUCOSE; GLUCOSE; INSULIN; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN; ANDROSTANE DERIVATIVE; ENZYME INHIBITOR; PHOSPHOTRANSFERASE; SOMATOMEDIN C; WORTMANNIN;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE TRANSPORT; HEART DISEASE; HYPERGLYCEMIA; INSULIN RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RISK FACTOR; VASCULAR SMOOTH MUSCLE; ANIMAL; CELL CULTURE; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; FOLLOW UP; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL; WISTAR RAT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANIMALS; BIOLOGICAL TRANSPORT; CELLS, CULTURED; DEOXYGLUCOSE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FOLLOW-UP STUDIES; GLUCOSE; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; MALE; MUSCLE, SMOOTH, VASCULAR; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RATS; RATS, WISTAR;

EID: 0030588330     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)05934-5     Document Type: Article

References (36)

1. [1] Ruderman NB, Williamson JR, Brownlee M. Glucose and diabetic vascular disease. FASEB J 1992;6:2905.
2. [2] DeFronzo RA. Lilly Lecture 1987: The triumvirate: β-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 1988;37:667.
3. [3] Rossetti L, Giaccari A, DeFronzo RA. Glucose toxicity. Diabetes Care 1990;13:610.
4. [4] DeFronzo RA, Hendler R, Simonson D. Insulin resistance is a prominent feature of insulin-dependent diabetes. Diabetes 1982;31:795.
5. [5] Yki-Jarvinen H, Koivisto VA. Natural course of insulin resistance in type I diabetes. N Engl J Med 1986;315:224.
6. [6] Fujiwara R, Kutsumi Y, Hayashi T et al. Relation of angiographically defined coronary artery disease and the plasma concentrations of insulin, lipid, and apolipoprotein in normolipidemic subjects with varying degrees of glucose tolerance. Am J Cardiol 1995;75:122.
7. 2+ uptake induced by insulin, IGF-I, and PDGF in vascular smooth muscle cells. Cardiovasc Drugs Ther 1994;8:861.
8. [8] Suzuki K, Kono T. Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from an intracellular storage site. Proc Natl Acad Sci USA 1980;77:2542.
9. [9] Cushman S.W, Wardzala LJ. Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. Apparent translocation of intracellular transport systems to the plasma membrane. J Biol Chem 1980;255:4758.
10. [10] Backer JM, Myers Jr MG, Sun X-J et al. Association of IRS-1 with the insulin receptor and the phosphatidylinositol 3′-kinase. Formation of binary and ternary signaling complexes in intact cells. J Biol Chem 1993;268:8204.
11. [11] Okamoto M, Hayashi T, Kono S et al. Specific activity of phosphatidylinositol 3-kinase is increased by insulin stimulation. Biochem J 1993;290:327.
12. [12] Kelly KL, Ruderman NB. Insulin-stimulated phosphatidylinositol 3-kinase. Association with a 185-kDa tyrosine-phosphorylated protein (IRS-1) and localization in a low density membrane vesicle. J Biol Chem 1993;268:4391.
13. [13] Ruderman NB, Kapeller R, White MF, Cantley LC. Activation of phosphatidylinositol 3-kinase by insulin. Proc Natl Acad Sci USA 1990;87:1411.
14. [14] Okada T, Sakuma L, Fukui Y, Hazeki O, Ui M. Blockage of chemotactic peptide-induced stimulation of neurophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase. J Biol Chem 1994;269:3563.
15. [15] Fujiwara R, Shimada A, Tamai T, Nakai T, Miyabo S. Effects of insulin, insulin-like growth factor-I, and phorbol esters on neutral cholesteryl esterase activity in cultured rat vascular smooth muscle cells. J Lab Clin Med 1995;126:240.
16. [16] Plagemann PGW, Richey DP. Transport of nucleosides, nucleic acid bases, choline and glucose by animal cells in culture. Biochim Biophys Acta 1974;344:263.
17. [17] Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagents. J Biol Chem 1951;193:265.
18. [18] Kaiser N, Sasson S, Feener EP et al. Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes 1993;42:80.
19. [19] Hiraki Y, Rosen OM, Birnbaum MJ. Growth factors rapidly induce expression of glucose transporter gene. J Biol Chem 1988;263:13655.
20. [20] Carter-Su C, Czech MP. Reconstitution of D-glucose transport activity from cytoplasmic membranes: evidence against recruitment of cytoplasmic membrane transporters into the plasma membrane as the sole action of insulin. J Biol Chem 1980;255:10382.
21. [21] Wardzala LJ, Jeanrenaud B. Potential mechanism of insulin action on glucose transport in the isolated rat diaphragm. Apparent translocation of intracellular transport units to the plasma membrane. J Biol Chem 1981;256:7090.
22. [22] Kono T, Suzuki K, Dansey LE, Robinson FW, Blevins TL. Energy-dependent and protein synthesis-independent recycling of the insulin-sensitive glucose transport mechanism in fat cells. J Biol Chem 1981;256:6400.
23. [23] Pfeifle B, Ditschuneit H. Two separate receptors for insulin and insulinlike growth factors on arterial smooth muscle cells. Exp Clin Endocrinol 1983;81:280.
24. [24] King GL, Goodman AD, Buzney S, Moses A, Kahn CR. Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest 1985;75:1028.
25. [25] Stout RW, Buchanan KD, Vallance-Owen J. Arterial lipid metabolism in relation to blood glucose and plasma insulin in rats with streptozotocin-induced diabetes. Diabetotogia 1972;8:398.
26. [26] Capron L, Housset E, Hartmann L. Effects of in vitro and in vivo exposure to insulin upon glucose carbon accumulation in rat aorta: different patterns of response for intima-media and adventitia. Metabolism 1980;29:859.
27. [27] Falholt K, Cutfield R, Alejandro R, Heding L, Mintz D. The effects of hyperinsulinemia on arterial wall and peripheral muscle metabolism in dogs. Metabolism 1985;34:1146.
28. [28] Taggart H, Stout RW. Control of DNA synthesis in cultured vascular endothelial and smooth muscle cells. Atherosclerosis 1980;37:549.
29. [29] Bornfeldt KE, Gidlof RA, Wasteson A, Lake M, Skottner A, Arnqvist HJ. Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities. Diabetologia 1991;34:307.
30. [30] Ganda OP. Pathogenesis of macrovascular disease in the human diabetic. Diabetes 1980;29:931.
31. [31] Sasson S, Cerasi E. Substrate regulation of the glucose transport system in rat skeletal muscle. J Biol Chem 1986;261:16827.
32. [32] Tordjman KM, Leingang KA, Mueckler M. Differential regulation of the HepG2 and adipocyte-muscle glucose transporters in 3T3L1 adipocytes: effect of chronic glucose deprivation. Biochem J 1990;271:201.
33. [33] Haspel C, Wilk EW, Birnbaum MJ, Cushman SW, Rosen OM. Glucose deprivation and hexose transporter polypeptides of murine fibroblasts. J Biol Chem 1986;261:6778.
34. [34] Garvey WT, Olefsky JM, Marshall S. Insulin induces progressive insulin resistance in cultured rat adipocytes. Sequential effects at receptor and multiple postreceptor sites. Diabetes 1986;35:258.
35. [35] Coughlin SR, Escobedo JA, Williams LT. Role of phosphatidylinositol kinase in PDGF receptor signal transduction. Science 1989;243:1191.
36. [36] Varticovski L, Druker B, Morrison D, Cantley L, Roberts T. The colony stimulating factor-1 receptor associates with and activates phosphatidylinositol-3 kinase. Nature 1989;342:699.